These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Neurologic markers of the progression of Alzheimer's disease. Franssen EH; Reisberg B Int Psychogeriatr; 1997; 9 Suppl 1():297-306; discussion 317-21. PubMed ID: 9447450 [TBL] [Abstract][Full Text] [Related]
6. Neurological signs in Alzheimer's disease. Burns A; Jacoby R; Levy R Age Ageing; 1991 Jan; 20(1):45-51. PubMed ID: 2028851 [TBL] [Abstract][Full Text] [Related]
7. Does executive impairment define a frontal variant of Alzheimer's disease? Woodward M; Brodaty H; Boundy K; Ames D; Blanch G; Balshaw R; Int Psychogeriatr; 2010 Dec; 22(8):1280-90. PubMed ID: 20719041 [TBL] [Abstract][Full Text] [Related]
8. Extrapyramidal symptoms and signs in Alzheimer's disease: prevalence and correlation with the first symptom. Tsolaki M; Kokarida K; Iakovidou V; Stilopoulos E; Meimaris J; Kazis A Am J Alzheimers Dis Other Demen; 2001; 16(5):268-78. PubMed ID: 11603162 [TBL] [Abstract][Full Text] [Related]
9. [Standardized neurologic study in senile dementia of Alzheimer's type]. Davous P; Lamour Y; Roudier M Encephale; 1989; 15(4):387-96. PubMed ID: 2680461 [TBL] [Abstract][Full Text] [Related]
10. Identifying Patterns in Signs and Symptoms Preceding the Clinical Diagnosis of Alzheimer's Disease: Retrospective Medical Record Review Study and a Nested Case-control Design. Bature F; Pang D; Robinson A; Polson N; Pappas Y; Guinn B Curr Alzheimer Res; 2018; 15(8):723-730. PubMed ID: 29623839 [TBL] [Abstract][Full Text] [Related]
11. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice]. Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552 [TBL] [Abstract][Full Text] [Related]
12. Amyloid burden and metabolic function in early-onset Alzheimer's disease: parietal lobe involvement. Ossenkoppele R; Zwan MD; Tolboom N; van Assema DM; Adriaanse SF; Kloet RW; Boellaard R; Windhorst AD; Barkhof F; Lammertsma AA; Scheltens P; van der Flier WM; van Berckel BN Brain; 2012 Jul; 135(Pt 7):2115-25. PubMed ID: 22556189 [TBL] [Abstract][Full Text] [Related]
13. Correlation of rCBF (SPECT), CSF tau, and cognitive function in patients with dementia of the Alzheimer's type, other types of dementia, and control subjects. Tsolaki M; Sakka V; Gerasimou G; Dimacopoulos N; Chatzizisi O; Fountoulakis KN; Kyriazis G; Papanastasiou J; Kazis A Am J Alzheimers Dis Other Demen; 2001; 16(1):21-31. PubMed ID: 11416945 [TBL] [Abstract][Full Text] [Related]
18. Psychosis in Alzheimer's disease is associated with frontal metabolic impairment and accelerated decline in working memory: findings from the Alzheimer's Disease Neuroimaging Initiative. Koppel J; Sunday S; Goldberg TE; Davies P; Christen E; Greenwald BS; Am J Geriatr Psychiatry; 2014 Jul; 22(7):698-707. PubMed ID: 23672944 [TBL] [Abstract][Full Text] [Related]
19. Value of neuropsychological tests, neuroimaging, and biomarkers for diagnosing Alzheimer's disease in younger and older age cohorts. Schmand B; Eikelenboom P; van Gool WA; J Am Geriatr Soc; 2011 Sep; 59(9):1705-10. PubMed ID: 21883100 [TBL] [Abstract][Full Text] [Related]
20. Alzheimer's disease or Alzheimer's syndrome?: a longitudinal computed tomography neuroradiological follow-up study of 56 cases diagnosed clinically as Alzheimer's disease. Fujisawa K; Tsunoda S; Hino H; Shibuya K; Takeda A; Aoki N Psychogeriatrics; 2015 Dec; 15(4):255-71. PubMed ID: 26767569 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]